NeuroSense Therapeutics Ltd. Other Nonoperating Income (Expense)
NeuroSense Therapeutics Ltd. (NRSN) reported Other Nonoperating Income (Expense) of -$448.00 thousand for the 12-month period ending 2023-12-31, per its 6-K filed 2024-06-17.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2024-06-17
| Period end | Other Nonoperating Income (Expense) 12 month |
|---|---|
| 2023-12-31 | -$448.00K 6-K · filed 2024-06-17 |
| 2022-12-31 | -$29.00K 6-K · filed 2024-06-17 |
| 2021-12-31 | -$235.00K 6-K · filed 2024-06-17 |